GTC—NVIDIA today introduced Clara Holoscan MGX™, a
platform for the medical device industry to develop and deploy
real-time AI applications at the edge, specifically designed to
meet required regulatory standards.
Clara Holoscan MGX expands the Clara Holoscan platform to
provide an all-in-one, medical-grade reference architecture, as
well as long-term software support, to accelerate innovation in the
medical device industry. It brings a new level of sensor innovation
to edge computing by processing high-throughput data streams for
real-time insights. From robotic surgery to studying new approaches
to biology, surgeons and scientists need medical devices to evolve
into continuous sensing systems to research and treat disease.
“Deploying real-time AI in healthcare and life sciences is
critical to enable the next frontiers in surgery, diagnostics and
drug discovery,” said Kimberly Powell, vice president of healthcare
at NVIDIA. “Clara Holoscan MGX, with its unique combination of AI,
accelerated computing and advanced visualization, accelerates the
productization of AI and provides software-as-a-service business
models for the medical device industry.”
As part of Clara Holoscan MGX, NVIDIA provides hardware
reference design with long-life NVIDIA components and 10-year
long-term software support, including IEC62304 documentation for
software and IEC60601 attestation reports from embedded computing
partners.
ADLINK, Advantech, Dedicated Computing, Kontron, Leadtek, MBX
Systems, Onyx Healthcare, Portwell, Prodrive Technologies, RYOYO
Electro and Yuan High-Tech will be the first embedded-computing
manufacturers to build products based on the Clara Holoscan MGX
reference design to serve the needs of the global medical device
industry.
Some of the largest medical devices makers and dozens of robotic
surgery and medical imaging startups are already developing on the
Clara Holoscan platform.
Product SpecificationsClara Holoscan MGX brings
together the high-performance NVIDIA Jetson AGX Orin™ Industrial
module, NVIDIA RTX™ A6000 GPU and NVIDIA ConnectX-7® SmartNIC
network adapter into a scalable AI platform providing up to 254-619
trillion operations per second of AI performance.
For high-throughput instruments, ConnectX-7 provides up to 200
GbE bandwidth and a GPUDirect® RDMA path to GPU processing, which
helps enable faster processing. It also integrates the latest in
embedded security with a safety and security module, consisting of
controllers to monitor critical operations, provide remote software
updates and system recovery, and hardware root of trust to provide
state-of-the-art embedded security.
Medical device makers can directly embed Clara Holoscan MGX or
connect to the existing install base of medical devices, which
allows developers to accelerate AI deployment and regulatory
clearance.
The Clara Holoscan SDK is specifically designed for
high-performance streaming applications to build the next
generation of software-defined instruments. It brings together
pretrained models, as well as a framework for scalable
microservices, to allow applications to be managed and deployed
both on device and on the edge data center, ushering in the
software-as-a-service business model for the industry.
Clara Holoscan extends from medical devices to NVIDIA edge
servers to NVIDIA DGX™ systems in the cloud or the data center.
Clara Holoscan developer kits are available today. Join the
interest list for Clara Holoscan MGX to get notified about
availability.
To learn more about Clara Holoscan MGX, watch the GTC 2022
keynote from NVIDIA CEO Jensen Huang. Register for GTC for free to
attend sessions with NVIDIA and industry leaders.
About NVIDIANVIDIA’s (NASDAQ: NVDA) invention
of the GPU in 1999 sparked the growth of the PC gaming market and
has redefined modern computer graphics, high performance computing
and artificial intelligence. The company’s pioneering work in
accelerated computing and AI is reshaping trillion-dollar
industries, such as transportation, healthcare and manufacturing,
and fueling the growth of many others. More information at
https://nvidianews.nvidia.com/.
For further information, contact:Janette
CiborowskiNVIDIA
Corporation+1-734-330-8817jciborowski@nvidia.com
Certain statements in this press release including, but not
limited to, statements as to: the benefits, impact, and performance
of our products and technologies, including Clara Holoscan MGX, the
Clara Holoscan platform, NVIDIA Jetson AGX Orin, NVIDIA RTX A6000
GPU and NVIDIA ConnectX-7 SmartNIC; deploying real-time AI in
healthcare and life sciences being critical to enable the next
frontiers in surgery, diagnostics and drug discovery;
embedded-computing manufacturers building products based on the
Clara Holoscan MGX reference design; and the next generation of
software-defined instruments are forward-looking statements that
are subject to risks and uncertainties that could cause results to
be materially different than expectations. Important factors that
could cause actual results to differ materially include: global
economic conditions; our reliance on third parties to manufacture,
assemble, package and test our products; the impact of
technological development and competition; development of new
products and technologies or enhancements to our existing product
and technologies; market acceptance of our products or our
partners’ products; design, manufacturing or software defects;
changes in consumer preferences or demands; changes in industry
standards and interfaces; unexpected loss of performance of our
products or technologies when integrated into systems; as well as
other factors detailed from time to time in the most recent reports
NVIDIA files with the Securities and Exchange Commission, or SEC,
including, but not limited to, its annual report on Form 10-K and
quarterly reports on Form 10-Q. Copies of reports filed with the
SEC are posted on the company’s website and are available from
NVIDIA without charge. These forward-looking statements are not
guarantees of future performance and speak only as of the date
hereof, and, except as required by law, NVIDIA disclaims any
obligation to update these forward-looking statements to reflect
future events or circumstances.
© 2022 NVIDIA Corporation. All rights reserved. NVIDIA, the
NVIDIA logo, AGX Orin, ConnectX, DGX, GPUDirect, NVIDIA Clara
Holoscan MGX and NVIDIA RTX are trademarks and/or registered
trademarks of NVIDIA Corporation and/or Mellanox Technologies in
the U.S. and other countries. All other trademarks and copyrights
are the property of their respective owners. Features, pricing,
availability, and specifications are subject to change without
notice.
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/256c643a-1e42-4cce-ab31-db87a3748cb2
NVIDIA (NASDAQ:NVDA)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
NVIDIA (NASDAQ:NVDA)
Historical Stock Chart
Von Apr 2023 bis Apr 2024